Avoro Capital Advisors LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$6.86B
Signature - Title
Scott Epstein - Chief Compliance Officer & COO
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Avoro Capital Advisors LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Avoro Capital Advisors LLC reported 35 stock holdings with total value $6.86B as of Q3 2024. Top holdings included UTHR, ASND, ARGX, KRYS, and MDGL.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 35 $6.86B +$301M -$1.13B -$827M UTHR, ASND, ARGX, KRYS, MDGL 13F-HR 11/14/2024, 07:59 AM
Q2 2024 41 $7.51B +$255M -$1.18B -$924M UTHR, MDGL, ASND, ARGX, SRPT 13F-HR 8/14/2024, 07:58 AM
Q1 2024 46 $8.57B +$1.7B -$873M +$830M UTHR, APLS, ASND, SRPT, MDGL 13F-HR 5/15/2024, 08:07 AM
Q4 2023 42 $7.24B +$1.5B -$1.48B +$16.3M APLS, UTHR, ASND, ARGX, MDGL 13F-HR 2/14/2024, 12:05 PM
Q3 2023 45 $6.41B +$266M -$764M -$498M HZNP, UTHR, ARGX, SRPT, APLS 13F-HR 11/14/2023, 06:32 AM
Q2 2023 43 $7.37B +$486M -$166M +$320M APLS, HZNP, UTHR, SRPT, ARGX 13F-HR 8/14/2023, 07:33 AM
Q1 2023 38 $6.74B +$304M -$21.4M +$283M HZNP, APLS, UTHR, SRPT, ARGX 13F-HR 5/15/2023, 09:09 AM
Q4 2022 36 $6.69B +$473M -$55.7M +$417M UTHR, HZNP, APLS, MDGL, ARGX 13F-HR 2/14/2023, 09:04 AM
Q3 2022 39 $5.41B +$264M -$196M +$68.8M APLS, UTHR, ARGX, MRTX, SRPT 13F-HR 11/14/2022, 09:28 AM
Q2 2022 40 $5.06B +$322M -$395M -$73M UTHR, ARGX, APLS, HZNP, MRTX 13F-HR 8/15/2022, 08:54 AM
Q1 2022 43 $5.48B +$789M -$411M +$377M HZNP, UTHR, APLS, MRTX, ARGX 13F-HR 5/16/2022, 08:57 AM
Q4 2021 40 $5.86B +$640M -$1.23B -$589M HZNP, MRTX, UTHR, APLS, ARGX 13F-HR 2/14/2022, 09:03 AM
Q3 2021 43 $6.34B +$603M -$364M +$239M HZNP, MRTX, XLRN, UTHR, ASND 13F-HR 11/15/2021, 09:04 AM
Q2 2021 44 $5.74B +$644M -$498M +$147M HZNP, MRTX, UTHR, XLRN, ARGX 13F-HR 8/16/2021, 09:05 AM
Q1 2021 46 $5.79B +$1.09B -$373M +$721M HZNP, MRTX, UTHR, XLRN, VRTX 13F-HR 5/17/2021, 09:29 AM
Q4 2020 43 $5.81B +$1.14B -$3.07B -$1.93B MRTX, HZNP, UTHR, IOVA, ARNA 13F-HR 2/16/2021, 12:33 PM
Q3 2020 46 $7.04B +$727M -$353M +$374M IMMU, MRTX, HZNP, IOVA, ASND 13F-HR 11/16/2020, 09:02 AM
Q2 2020 44 $5.06B +$743M -$193M +$550M IMMU, MRTX, HZNP, IOVA, SRPT 13F-HR 8/14/2020, 10:00 AM
Q1 2020 41 $2.96B +$489M -$50.7M +$439M IMMU, MRTX, IOVA, ASND, BMRN 13F-HR 5/15/2020, 01:03 PM
Q4 2019 29 $3.4B +$494M -$515M -$20.6M IMMU, MRTX, ASND, IOVA, SRPT 13F-HR 2/14/2020, 09:47 AM
Q3 2019 33 $2.4B +$220M -$168M +$51.9M MRTX, IMMU, IOVA, ASND, BMRN 13F-HR 11/14/2019, 12:40 PM
Q2 2019 33 $2.89B +$531M -$176M +$354M MRTX, IMMU, IOVA, ASND, SRPT 13F-HR 8/14/2019, 12:04 PM
Q1 2019 31 $2.31B +$299M -$249M +$50.2M IMMU, MRTX, ASND, AMRN, SRPT 13F-HR 5/15/2019, 12:26 PM
Q4 2018 33 $1.67B +$198M -$306M -$107M IMMU, MRTX, SRPT, ASND, BMRN 13F-HR 2/14/2019, 11:11 AM
Q3 2018 43 $2.18B +$170M -$536M -$366M IMMU, MRTX, SRPT, ASND, BMRN 13F-HR 11/14/2018, 11:16 AM
Q2 2018 41 $2.59B +$690M -$444M +$246M IMMU, MRTX, BMRN, FOLD, ASND 13F-HR 8/14/2018, 11:25 AM
Q1 2018 50 $2.09B +$561M -$148M +$413M IMMU, FOLD, BMRN, IOVA, MRTX 13F-HR 5/15/2018, 12:51 PM
Q4 2017 44 $1.53B +$360M -$171M +$190M IMMU, BMRN, FOLD, MRTX, CLVSQ 13F-HR 2/14/2018, 11:43 AM
Q3 2017 39 $1.27B +$446M -$152M +$293M IMMU, FOLD, KITE, ARRY, CLVSQ 13F-HR 11/14/2017, 12:23 PM
Q2 2017 42 $789M +$188M -$197M -$9.52M IMMU, KITE, FOLD, TSRO, BMRN 13F-HR 8/14/2017, 12:30 PM
Q1 2017 42 $782M +$310M -$127M +$183M IMMU, TSRO, MDCO, ACAD, BMRN 13F-HR 5/15/2017, 12:20 PM
Q4 2016 39 $494M +$101M -$81M +$19.6M ACAD, IMMU, BMRN, LBIO, TSRO 13F-HR 2/14/2017, 12:27 PM
Q3 2016 44 $563M +$109M -$116M -$7.06M SRPT, BMRN, LBIO, TSRO, FOLD 13F-HR 11/14/2016, 03:38 PM
Q2 2016 38 $445M +$184M -$41.2M +$143M TSRO, LBIO, CPXX, BMRN, BMY 13F-HR 8/15/2016, 04:09 PM
Q1 2016 33 $284M +$129M -$52.2M +$76.5M MRTX, FOLD, BMRN, SRPT, GILD 13F-HR 5/16/2016, 04:06 PM
Q4 2015 28 $290M +$23.4M -$92.2M -$68.8M MRTX, FOLD, LBIO, LJPC, SRPT 13F-HR 2/12/2016, 12:00 PM
Q3 2015 29 $378M +$124M -$43.9M +$79.8M FOLD, MRTX, VNDA, LJPC, ACAD 13F-HR 11/13/2015, 12:27 PM
Q2 2015 30 $362M +$142M -$77.5M +$64.2M FOLD, SRNE, MRTX, LBIO, ONTY 13F-HR 8/14/2015, 12:31 PM
Q1 2015 33 $261M +$138M -$39.4M +$98.2M FOLD, LBIO, SRNE, PTX, BLCM 13F-HR 5/15/2015, 11:59 AM
Q4 2014 27 $144M $0 $0 FOLD, TARO, RCPT, PTX, AGEN 13F-HR 2/13/2015, 01:07 PM